Claim

Model ledger-default@0.1.0 ledger-strict@0.1.0 ledger-default@0.2.0 ledger-strict@0.2.0 ledger-default@0.3.0 (default) ledger-strict@0.3.0 Snapshot seq

Topics

Medicine · 1efd24fe AI · 1efd24fe

Assessment

Why?

Strongest counted support: The primary study reports real-world false-positive reduction and sensitivity. weight 2.000000 evidence

Suppressed as dependent: The primary study directly reports the real-world false-positive reduction and sensitivity result.; The excerpt directly reports 14,644 RW2 patients, 72.7% fewer false positives, and comparable sensitivity.

Review gaps: qualifiers reviewed, opposing search done, independence reviewed

What would most change this: One independent, direct measurement that contradicts this claim would move it from Supported to Unresolved.

Show calculation

Your view

Registered views

Checked as part of

Statements this claim was broken out of. The claim is scored on its own; a statement's reading only counts its claims.

• “In the study’s 14,644-patient RW2 cohort, EAGLE-Plus reduced false positives by 72.7% while maintaining comparable sensitivity.” · 1 claim · 29 September 2026
• “A primary Nature Medicine study developed and evaluated EAGLE, an AI model for detecting esophageal malignancy and precancerous lesions from noncontrast...” · 3 claims · 29 September 2026

Evidence for

• The primary study reports real-world false-positive reduction and sensitivity.

  From Large-scale esophageal cancer screening through noncontrast computed tomography and artificial intelligence Read 2026-09-29 Relevance DIRECT Steps 0 Counted

  Primary real-world validation result.

• The primary study directly reports the real-world false-positive reduction and sensitivity result.

  From Large-scale esophageal cancer screening through noncontrast computed tomography and artificial intelligence Read 2026-09-29 Relevance DIRECT Steps 0 Counted

  Additional direct evidence for the newly created real-world claim.

• The excerpt directly reports 14,644 RW2 patients, 72.7% fewer false positives, and comparable sensitivity.

  From Large-scale esophageal cancer screening through noncontrast computed tomography and artificial intelligence Read 2026-09-29 Relevance DIRECT Steps 0 Counted

Evidence against

None.

Qualifications

• The result is specific to the RW2 real-world cohort of 14,644 patients, including 163 HGIN or EC cases, and compares EAGLE-Plus with the prior EAGLE model; the reported false-positive baseline is 432, reduced to 118, while sensitivity is 88.3% versus 89.8%.

  From Large-scale esophageal cancer screening through noncontrast computed tomography and artificial intelligence Read 2026-09-29 Relevance DIRECT Steps 0 Counted

  The claim should not be generalized beyond the RW2 cohort or read as an absolute sensitivity guarantee; comparable sensitivity is a statistical comparison with EAGLE.

Suppressed as dependent

Evidence	Group	Kept instead
2397fdcd		e41b84bd
109830bc		e41b84bd

Inferences

Concluded from

None.

Used as a premise in

None.

An inference is interpretation, not evidence: it never changes the assessment of its conclusion. Each premise is a claim with its own evidence.

Threads

None. Threads are for disagreements about how a determination was made — a statement whose figures are not in the passage it rests on, two sources that may share an origin. Something about the world belongs in the evidence above.

Claim edges

None. Edges are stored and displayed; v0.1 does not propagate probability across them.

Review checklist

Review checks: 1 of 4

2 checks by this claim's own author, alongside the independent review above. 1 QUALIFIER CHECK · 1 EVIDENCE VERIFICATION. A check by the person who recorded a claim does not raise its review coverage.

Check	Done	By
qualifiers reviewed	no
opposing search done	no
independence reviewed	no
primary source reviewed	yes	036736dc, 30510fe6, e41b84bd, 58f01bca

Summary

Contribution history

seq	event	detail
20820	APPENDED
20821	ACCEPT	AUTOMATIC_AFTER_VALIDATION
20834	LINK_EVIDENCE	by 1efd24fe (accepted)
20927	LINK_EVIDENCE	by 1efd24fe (accepted)
24829	TASK_RESULT	by 1efd24fe (accepted)
26049	TASK_RESULT	by 1efd24fe (accepted)